Comparative Effects of Mycobacterium Avium Glycopeptidolipid and Lipopeptide Fragment on the Function and Ultrastructure of Mononuclear Cells

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1993 Jul 1

PMID 8324905

Citations 11

Authors

M Pourshafie

Q Ayub

W W Barrow

Affiliations

Soon will be listed here.

Abstract

Among the various lipids associated with the cell envelope of the Mycobacterium avium complex, the species-specific glycopeptidolipids (GPL) are responsible for distinguishing one serovar from another. In a continuing effort to study the immunomodulatory capabilities of these mycobacterial lipids, we have examined and compared the effects of the GPL and its lipopeptide fragment (beta-lipid) on mononuclear cell function. It was observed that the lymphoproliferative response of murine splenic mononuclear cells to mitogen stimulation was reduced by both the GPL and its lipopeptide fragment. Although the responsiveness appeared to be down-regulated to a greater degree by the beta-lipid, treatment with either GPL or beta-lipid resulted in the release of soluble factors from peritoneal macrophages that caused suppression of the lymphoproliferative responsiveness of splenic mononuclear cells. Flow cytometric analysis of peritoneal macrophages revealed that treatment with the beta-lipid fragment caused a marked decrease in expression of the C3bi complement receptor, Mac-1, on macrophages, whereas treatment with GPL resulted in a marked increase in the expression of Mac-2 receptor on macrophages. Treatment of peritoneal macrophages with either GPL or beta-lipid resulted in the release of tumour necrosis factor (TNF), as determined by an L929 biological cytotoxicity assay. Perturbation of macrophage membrane ultrastructure by both GPL and beta-lipid was confirmed by electron microscopy, and may be a possible explanation for the resulting alterations in mononuclear cell function observed in this study.

Citing Articles

Engineering Synthetic Lipopeptide Antigen for Specific Detection of subsp. Infection.

Bay S, Begg D, Ganneau C, Branger M, Cochard T, Bannantine J Front Vet Sci. 2021; 8:637841.

PMID: 33969035 PMC: 8103206. DOI: 10.3389/fvets.2021.637841.

Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.

Daffe M, Crick D, Jackson M Microbiol Spectr. 2014; 2(4).

PMID: 25485178 PMC: 4255156. DOI: 10.1128/microbiolspec.MGM2-0021-2013.

Production of reactive oxygen (H2O2) and nitrogen (NO) intermediates and tnf-α in mice genetically selected for high (H) and low (L) antibody response and experimentally infected with Leptospira serovar pomona.

Haanwinckel M, de Oliveira S Braz J Microbiol. 2013; 42(2):729-39.

PMID: 24031688 PMC: 3769827. DOI: 10.1590/S1517-838220110002000041.

Mannose receptor-dependent delay in phagosome maturation by Mycobacterium avium glycopeptidolipids.

Sweet L, Singh P, Azad A, Rajaram M, Schlesinger L, Schorey J Infect Immun. 2009; 78(1):518-26.

PMID: 19841083 PMC: 2798179. DOI: 10.1128/IAI.00257-09.

The mycobacterial glycopeptidolipids: structure, function, and their role in pathogenesis.

Schorey J, Sweet L Glycobiology. 2008; 18(11):832-41.

PMID: 18723691 PMC: 2733780. DOI: 10.1093/glycob/cwn076.

References

Watson G, Fu Y, Lopez D . Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms. J Leukoc Biol. 1991; 49(2):126-38. DOI: 10.1002/jlb.49.2.126. View

Tsuyuguchi I, Kawasumi H, Takashima T, Tsuyuguchi T, Kishimoto S . Mycobacterium avium-Mycobacterium intracellular complex-induced suppression of T-cell proliferation in vitro by regulation of monocyte accessory cell activity. Infect Immun. 1990; 58(5):1369-78. PMC: 258634. DOI: 10.1128/iai.58.5.1369-1378.1990. View

Drevets D, Campbell P . Roles of complement and complement receptor type 3 in phagocytosis of Listeria monocytogenes by inflammatory mouse peritoneal macrophages. Infect Immun. 1991; 59(8):2645-52. PMC: 258068. DOI: 10.1128/iai.59.8.2645-2652.1991. View

Sussman G, Wadee A . Production of a suppressor factor by CD8+ lymphocytes activated by mycobacterial components. Infect Immun. 1991; 59(8):2828-35. PMC: 258093. DOI: 10.1128/iai.59.8.2828-2835.1991. View

Laughon B, Allaudeen H, Becker J, Current W, Feinberg J, FRENKEL J . From the National Institutes of Health. Summary of the workshop on future directions in discovery and development of therapeutic agents for opportunistic infections associated with AIDS. J Infect Dis. 1991; 164(2):244-51. DOI: 10.1093/infdis/164.2.244. View

Barrow W . Contributing factors of pathogenesis in the Mycobacterium avium complex. Res Microbiol. 1991; 142(4):427-33. DOI: 10.1016/0923-2508(91)90115-q. View

Rulong S, Aguas A, Da Silva P, Silva M . Intramacrophagic Mycobacterium avium bacilli are coated by a multiple lamellar structure: freeze fracture analysis of infected mouse liver. Infect Immun. 1991; 59(11):3895-902. PMC: 258974. DOI: 10.1128/iai.59.11.3895-3902.1991. View

Newman G, Gan H, McCarthy Jr P, Remold H . Survival of human macrophages infected with Mycobacterium avium intracellulare correlates with increased production of tumor necrosis factor-alpha and IL-6. J Immunol. 1991; 147(11):3942-8. View

Wright E, Barrow W . Inhibition of glycopeptidolipid synthesis resulting from treatment of Mycobacterium avium with 2-deoxy-D-glucose. Res Microbiol. 1991; 142(5):597-608. DOI: 10.1016/0923-2508(91)90193-e. View

10.

Ellner J . Sources of variability in assays of the interaction of mycobacteria with mononuclear phagocytes: of mice and men. Res Microbiol. 1990; 141(2):237-40. DOI: 10.1016/0923-2508(90)90036-p. View

11.

Bermudez L, Young L . Killing of Mycobacterium avium: insights provided by the use of recombinant cytokines. Res Microbiol. 1990; 141(2):241-3. DOI: 10.1016/0923-2508(90)90037-q. View

12.

Tomioka H, Saito H, Yamada Y . Characteristics of immunosuppressive macrophages induced in spleen cells by Mycobacterium avium complex infections in mice. J Gen Microbiol. 1990; 136(5):965-73. DOI: 10.1099/00221287-136-5-965. View

13.

Sut A, Sirugue S, Sixou S, Lakhdar-Ghazal F, Tocanne J, LANEELLE G . Mycobacteria glycolipids as potential pathogenicity effectors: alteration of model and natural membranes. Biochemistry. 1990; 29(36):8498-502. DOI: 10.1021/bi00488a042. View

14.

Hubbard R, Collins F . Immunomodulation of mouse macrophage killing of Mycobacterium avium in vitro. Infect Immun. 1991; 59(2):570-4. PMC: 257789. DOI: 10.1128/iai.59.2.570-574.1991. View

15.

Tassell S, Pourshafie M, Wright E, Richmond M, Barrow W . Modified lymphocyte response to mitogens induced by the lipopeptide fragment derived from Mycobacterium avium serovar-specific glycopeptidolipids. Infect Immun. 1992; 60(2):706-11. PMC: 257690. DOI: 10.1128/iai.60.2.706-711.1992. View

16.

Mosser D, Springer T, Diamond M . Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18). J Cell Biol. 1992; 116(2):511-20. PMC: 2289275. DOI: 10.1083/jcb.116.2.511. View

17.

Rastogi N, Bachelet M, Carvalho de Sousa J . Intracellular growth of Mycobacterium avium in human macrophages is linked to the increased synthesis of prostaglandin E2 and inhibition of the phagosome-lysosome fusions. FEMS Microbiol Immunol. 1992; 4(5):273-9. DOI: 10.1111/j.1574-6968.1992.tb05006.x. View

18.

Carvalho de Sousa J, Bachelet M, Rastogi N . Effect of indomethacin on the modulation of Mycobacterium avium growth in human macrophages by interferon gamma, retinoic acid and 1,25(OH)2-vitamin D3. FEMS Microbiol Immunol. 1992; 4(5):281-6. DOI: 10.1111/j.1574-6968.1992.tb05007.x. View

19.

Draper P, Rees R . Electron-transparent zone of mycobacteria may be a defence mechanism. Nature. 1970; 228(5274):860-1. DOI: 10.1038/228860a0. View

20.

Brennan P, Goren M . Structural studies on the type-specific antigens and lipids of the mycobacterium avium. Mycobacterium intracellulare. Mycobacterium scrofulaceum serocomplex. Mycobacterium intracellulare serotype 9. J Biol Chem. 1979; 254(10):4205-11. View